Glaucius Oliva

São Carlos Institute of Physics, University of Sao Paulo

Affiliated withUniversity of Sao Paulo

Research Area

Immunology and Infection

Biography

Glaucius Oliva has not added Biography.
If you are Glaucius Oliva and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 8	2021

Other Publications

Article	Year
Cloning, characterization and preliminary crystallographic analysis of Leishmania hypoxanthine-guanine phosphoribosyltransferase. Biochimica et biophysica acta\| PubMed ID: 12147338	2002
In silico screening strategies for novel inhibitors of parasitic diseases. Expert opinion on drug discovery\| PubMed ID: 22646074	2011
Molecular docking and structure-based drug design strategies. Molecules (Basel, Switzerland)\| PubMed ID: 26205061	2015
Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase. Nature communications\| PubMed ID: 28345596	2017
New Molecular Targets and Strategies for Antimalarial Discovery. Current medicinal chemistry\| PubMed ID: 28875841	2019
Discovery of Marinoquinolines as Potent and Fast-Acting Plasmodium falciparum Inhibitors with in Vivo Activity. Journal of medicinal chemistry\| PubMed ID: 29879353	2018
Structural and mechanistic insight from antiviral and antiparasitic enzyme drug targets for tropical infectious diseases. Current opinion in structural biology\| PubMed ID: 30954758	2019
Phthalimide Derivatives with Bioactivity against : Synthesis, Evaluation, and Computational Studies Involving Cytochrome Inhibition. ACS omega\| PubMed ID: 31459076	2018
Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach. Journal of chemical information and modeling\| PubMed ID: 31765144	2020
A diarylamine derived from anthranilic acid inhibits ZIKV replication. Scientific reports\| PubMed ID: 31776405	2019
Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies. Malaria journal\| PubMed ID: 31888654	2019
Structural characterization and polymorphism analysis of the NS2B-NS3 protease from the 2017 Brazilian circulating strain of Yellow Fever virus. Biochimica et biophysica acta. General subjects\| PubMed ID: 31931019	2020
Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses. Viruses\| PubMed ID: 32486283	2020
Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors. Bioorganic chemistry\| PubMed ID: 33636437	2021
Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening. Virus research\| PubMed ID: 33887282	2021
A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process. Journal of molecular biology\| PubMed ID: 34174328	2021
Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus. Journal of chemical information and modeling\| PubMed ID: 34286575	2021
Machine Learning Models Identify Inhibitors of SARS-CoV-2. Journal of chemical information and modeling\| PubMed ID: 34387990	2021
Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors. Molecules (Basel, Switzerland)\| PubMed ID: 34443484	2021